BUSINESS INFORM JOURNAL.

УКР

ENG

Search:

REGISTRATION CERTIFICATE

KV #19905-9705 PR dated 02.04.2013.

FOUNDERS

RESEARCH CENTRE FOR INDUSTRIAL DEVELOPMENT PROBLEMS of NAS (KHARKIV, UKRAINE)

According to the decision No. 802 of the National Council of Television and Radio Broadcasting of Ukraine dated 14.03.2024, is registered as a subject in the field of print media.
ID R30-03156

PUBLISHER

Liburkina L. M.

SITE SECTIONS

The Place of the European Union Countries in the Global Pharmaceutical Market
Shuba M. V., Honcharenko K. O.

Shuba, Maryna V., and Honcharenko, Kyrylo O. (2023) “The Place of the European Union Countries in the Global Pharmaceutical Market.” Business Inform 1:18–24.
https://doi.org/10.32983/2222-4459-2023-1-18-24

Section: International Economic Relations

Article is written in Ukrainian
Downloads/views: 6

Download article (pdf) -

UDC 338.4

Abstract:
The purpose of the article is to determine the current state, features and prospects of development of the European Union countries in the global pharmaceutical market. The article presents the main indicators of the EU pharmaceutical sector in 2000-2021. It is determined that the pharmaceutical industry remains a key factor in the development of the economy of many European countries and is one of the most knowledge-intensive sectors of the economy. It is found that in 2021 in the production of pharmaceutical products among the EU Member States, the leaders were Italy, Germany, France and Belgium. Indicators of the share of leading exporters and importers in international trade in pharmaceutical products in 2021 are presented. The EU countries occupy leading positions in international trade in pharmaceutical products. In the global market, the leading exporter of pharmaceutical products in recent years is Germany. The indicators of foreign trade in pharmaceutical products of the EU from 2002 to 2021 are considered. It is found that the share of trade in pharmaceutical products in the EU’s total foreign trade is gradually growing. In 2021, the EU’s main trading partner for pharmaceutical products was the USA and Switzerland. To measure the identified comparative advantages of EU countries in the pharmaceutical sector, the article calculates an index of identified comparative advantages. The result shows that the export potential of the pharmaceutical industry in 16 EU countries is realized, and 11 countries still do not have a comparative advantage. It is determined that the COVID-19 pandemic has an ambiguous impact on the EU pharmaceutical market. On the one hand, COVID-19 can be seen as a great opportunity for the EU pharmaceutical industry, on the other hand, the pandemic has created significant risks for the pharmaceutical sector. It is defined that the prospects for the participation of the EU countries in the global pharmaceutical market and the priority vectors of development of the European pharmaceutical sector depend, first of all, on legislation and on demographic changes.

Keywords: global pharmaceutical market, European Union, pharmaceutical sector, pharmaceutical products.

Fig.: 8. Tabl.: 2. Bibl.: 14.

Shuba Maryna V. – Candidate of Sciences (Economics), Associate Professor, Associate Professor, Department of International Economic Relations named after Artur Golikov, V. N. Karazin Kharkiv National University (4 Svobody Square, Kharkіv, 61022, Ukraine)
Email: [email protected]
Honcharenko Kyrylo O. – Student, Department of International Economic Relations named after Artur Holikov, V. N. Karazin Kharkiv National University (4 Svobody Square, Kharkіv, 61022, Ukraine)
Email: [email protected]

List of references in article

Dorovskyi, O. V., and Yaroshenko, I. V. “Porivnialna kharakterystyka farmatsevtychnykh rynkiv krain YeS ta SND“ [Comparison of Pharmaceutical Markets of the EU Member Countries and the CIS Countries]. Biznes Inform. 2014. https://www.business-inform.net/export_pdf/business-inform-2014-12_0-pages-47_61.pdf
Androshchuk, H. “Farmatsevtychna stratehiia dlia Yevropy“ [Pharmaceutical Strategy for Europe]. Yurydychna hazeta online. June 18, 2020. https://yur-gazeta.com/publications/practice/medichne-pravo-farmacevtika/farmacevtichna-strategiya-dlya-evropi.html
Daniell, R. “EC Pharma Strategy: The first steps towards a more sustainable industry?“ European Pharmaceutical Review. January 13, 2021. https://www.europeanpharmaceuticalreview.com/article/138978/ec-pharma-strategy-the-first-steps-towards-a-more-sustainable-industry/
Salikhova, O., and Honcharenko, D. “Challenges of the COVID-19 Pandemic to Pharmaceutical Manufacturing: The EU and Ukraine's Response“. Economy and Forecasting, no. 3 (2021): 88-113. DOI: https://doi.org/10.15407/econforecast2021.03.088
Blanc, L. “The European Pharmaceutical Industry in a Global Economy: what drives EU exports of pharmaceuticals?“ Bruges European Economic Research Papers. 2015. http://aei.pitt.edu/67344/1/beer31.pdf
“The Pharmaceutical Industry in Figures“. Key Data 2022. https://www.efpia.eu/media/637143/the-pharmaceutical-industry-in-figures-2022.pdf
Grassano, N. et al. “The 2021 EU industrial R&D investment scoreboard“. European Commission, Joint Research Centre. Publications Office of the European Union, 2022. https://data.europa.eu/doi/10.2760/559391
“Pharmaceutical industry in Italy - Statistics & Facts“. statista. https://www.statista.com/topics/6332/pharmaceutical-industry-in-italy/#topicHeader__wrapper
“Revenue of leading pharmaceutical markets in Europe in 2020“. statista. https://www.statista.com/statistics/316076/european-pharmaceutical-market-value-by-country/
“Pharmaceutical products“. ITC. https://www.trademap.org/Country_SelProduct_TS.aspx?nvpm=1%7c%7c%7c%7c%7c30%7c%7c%7c2%7c1%7c1%7c3%7c2%7c1%7c2%7c1%7c1%7c1
“International trade in medicinal and pharmaceutical products“. eurostat. https://ec.europa.eu/eurostat/statistics-explained/index.php?title=International_trade_in_medicinal_and_pharmaceutical_products#Increasing_share_in_total_trade
Salikhova, O. B. “Porivnialni perevahy farmatsevtychnykh industrii krain kriz pryzmu novykh indykatoriv“ [Comparative Advantages of National Pharmaceutical Industries through the Prism of New Indicators]. Statystyka Ukrainy, no. 2-3 (2020): 48-58. DOI: https://doi.org/10.31767/su.2-3(89-90)2020.02-03.06
Poliakova, K. “Naslidky pandemii COVID-19 dlia farmatsevtyky: vyklyky dlia haluzi ta dlia krainy. 2021“ [Consequences of the COVID-19 Pandemic for Pharmaceuticals: Challenges for the Industry and for the Country. 2021]. UAinfo. May 27, 2020. https://uainfo.org/blognews/1590588639-naslidki-pandemiyi-covid-19-dlya-farmatsevtiki-vikliki-dlya-galuzi.html
“A pharmaceutical strategy for Europe“. European Commission. https://health.ec.europa.eu/medicinal-products/pharmaceutical-strategy-europe_en

FOR AUTHORS

License Contract

Conditions of Publication

Article Requirements

Regulations on Peer-Reviewing

Publication Contract

Current Issue

Frequently asked questions

INFORMATION

The Plan of Scientific Conferences

OUR PARTNERS

Journal «The Problems of Economy»

The site and its metadata are licensed under CC BY-SA.

Write to webmaster